Get the Stockscreener App
0.59
4.52%
0.0255
After Hours:
.59
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health advances weight management device to clinical trials - MSN
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents - Yahoo Finance
Cosmos Health files patents for cancer treatments By Investing.com - Investing.com Australia
Cosmos Health advances weight management device to clinical trials By Investing.com - Investing.com South Africa
Cosmos Health Enters Final Development Phase of CCX0722 Weight M - WICZ
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - ACCESS Newswire
Cosmos Health's Novel Weight Loss Device Enters Clinical Phase, Eyes Massive $142B Market Opportunity - StockTitan
Cosmos Health files patents for cancer treatments - Investing.com India
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - ACCESS Newswire
AI Breakthrough: Cosmos Health's Dual Cancer Patents Could Revolutionize $25B Treatment Market - StockTitan
Cosmos Health Appoints Dimitris Moraitis as Vice President of Strategy & Operations - citybiz
Cosmos Health Strengthens Management Team with the Appointment o - WICZ
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - ACCESS Newswire
Analyzing Ratios: Cosmos Health Inc (COSM)’s Financial Story Unveiled - The Dwinnex
Cosmos Health secures a 10-year contract with Provident - MSN
Cosmos Health Requests Appeal from the Nasdaq Stock Market - ACCESS Newswire
Cosmos Health Inc (NASDAQ: COSM) Up 32.86% From 52-Week Low; YTD Jumps 4.63% – Here’s What To Do Now - Marketing Sentinel
Cosmos Health secures a 10-year contract with Provident By Investing.com - Investing.com South Africa
Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals - AOL
Cosmos Health's Cana Labs Signs 10-Year Manufacturing Deal With Provident Pharmaceuticals - Marketscreener.com
Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility - ACCESS Newswire
Major Pharma Contract: Cosmos Health to Manufacture Generic Versions of Lioresal, Zoloft - StockTitan
Cosmos Health Inc [COSM] Shares Fall Approximately -34.36% Over the Year - Knox Daily
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar - ACCESS Newswire
Major Middle East Expansion: Cosmos Health Lands Exclusive $578K Qatar Distribution Contract - StockTitan
Cosmos Health Inc (COSM)’s stock price range in the last year - US Post News
Deeper Dive: Understanding Cosmos Health Inc (COSM) Through its Various Ratios - The Dwinnex
Cosmos Health Files Patent Application for Multiple Sclerosis Treatment -February 05, 2025 at 12:02 pm EST - Marketscreener.com
Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market - ACCESS Newswire
Revolutionary MS Treatment Patent: Cosmos Health's AI Platform Targets $26B Market - StockTitan
Cosmos health CEO Grigorios Siokas acquires $34,000 in stock - MSN
Cosmos health CEO Grigorios Siokas acquires $34,000 in stock By Investing.com - Investing.com Australia
Cosmos Health files patent for allergy inflammation treatment - MSN
0.12%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):